Mohamed Gijon

Citrullinated Vimentin Presented on MHC-II in Tumor Cells Is a Target for CD4+ T-Cell–Mediated Antitumor Immunity

Victoria A. Brentville, Rachael L. Metheringham, Barbara Gunn et al. · Cancer Research · 2016 · 104 citations · Full text

Medicine, Immunology, Oncology +17

Combination vaccine based on citrullinated vimentin and enolase peptides induces potent CD4-mediated anti-tumor responses

Victoria A. Brentville, Rachael L. Metheringham, Ian Daniels et al. · Journal for ImmunoTherapy of Cancer · 2020 · 53 citations · Full text

Medicine, Immunology, Oncology +17

Targeting gp100 and TRP-2 with a DNA vaccine: Incorporating T cell epitopes with a human IgG1 antibody induces potent T cell responses that are associated with favourable clinical outcome in a phase I/II trial

Poulam M. Patel, Christian H. Ottensmeier, C Mulatero et al. · OncoImmunology · 2018 · 47 citations · Full text

Medicine, Immunology, Oncology +17

Citrullinated α-enolase is an effective target for anti-cancer immunity

Katherine Cook, Ian Daniels, Peter Symonds et al. · OncoImmunology · 2017 · 45 citations · Full text

Life Sciences, Immunology, Oncology +16

T cell repertoire to citrullinated self-peptides in healthy humans is not confined to the HLA-DR SE alleles; Targeting of citrullinated self-peptides presented by HLA-DP4 for tumour therapy

Victoria A. Brentville, Peter Symonds, Katherine Cook et al. · OncoImmunology · 2019 · 19 citations · Full text

Life Sciences, Immunology, Oncology +17